Anti-NMDA receptor encephalitis laboratory findings: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Anti-NMDA receptor encephalitis}} {{CMG}} ==Overview== ==Laboratory Findings== ==References== {{Reflist|2}} Category:Needs content Category:Rheumatology...")
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Anti-NMDA receptor encephalitis}}
{{Anti-NMDA receptor encephalitis}}
{{CMG}}
{{CMG}} AE {{DMakkar}}


==Overview==
==Overview==


==Laboratory Findings==
==Laboratory Findings==
CSF white blood cells are frequently elevated in fewer than 200/mm3, and pleocytosis is commonly observed. Protein concentration is either normal or modestly elevated, and 60% of patients have CSF-specific oligoclonal bands. Immunoglobulin G (IgG) index and oligoclonal band tests are clinically relevant since they can be aberrant in normal CSF cell counts and protein levels.


==References==
==References==

Revision as of 05:02, 9 February 2023

Anti-NMDA receptor encephalitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Anti-NMDA receptor encephalitis from Other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Anti-NMDA receptor encephalitis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anti-NMDA receptor encephalitis laboratory findings

CDC on Anti-NMDA receptor encephalitis laboratory findings

Anti-NMDA receptor encephalitis laboratory findings in the news

Blogs on Anti-NMDA receptor encephalitis laboratory findings

Directions to Hospitals Treating Anti-NMDA receptor encephalitis

Risk calculators and risk factors for Anti-NMDA receptor encephalitis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] AE Dheeraj Makkar, M.D.[2]

Overview

Laboratory Findings

CSF white blood cells are frequently elevated in fewer than 200/mm3, and pleocytosis is commonly observed. Protein concentration is either normal or modestly elevated, and 60% of patients have CSF-specific oligoclonal bands. Immunoglobulin G (IgG) index and oligoclonal band tests are clinically relevant since they can be aberrant in normal CSF cell counts and protein levels.

References

Template:WH Template:WS